2502 Bickford Ave Snohomish, WA 98290
This exceptional 12.42-acre property in Snohomish, WA, presents a unique investment opportunity encompassing four tax parcels. The site boasts an approved site plan for a substantial 187,000 square foot, four-story building, permitted as a 217-bed substance abuse treatment facility. This approval includes all necessary permits, such as the Building Location Approval (BLA), SEPA compliance, Hearing Examiner approval, critical area approval, and a Hydraulic Project Approval (HPA) for a bridge. Furthermore, the property includes a separate residential parcel approved for the construction of 29 single-family homes complete with a clubhouse. Adding to its versatility, the zoning allows for the development of mini-storage facilities, with potential for over 900 units. The property's strategic location directly across from a major shopping and retail center ensures high visibility and convenient accessibility. All essential utilities—power, water, sewer, gas, and cable—are readily available on-site. The comprehensive approvals and existing site plan significantly streamline the development process, minimizing potential delays and uncertainties. This property offers a rare combination of approved uses and prime location, making it an ideal investment for developers seeking a multi-faceted project with significant return potential. The DOE stormwater approval is also in place. Buyer is responsible for verifying all information.
Cap rate
Implied · in-place · derived from last sale + estimated NOIValue
AI, CAP & Alternative Use estimations · Realmo proprietary blendComparables
6 recent transactions · within 1.5 miComparable in this City
Similar Nearby for Sale
Similar Nearby for Lease
Property description
Physical attributes from public recordsZoning & alternative use
No recorded transactions found for this property.
Costs & Benchmarks
Operating expenses, capex projections, utility benchmarks, and submarket comparables — all in one view.
Risks
Flood, climate, environmental, title, and tenant-concentration risk — surfaced with mitigations and source citations.